Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $271,174.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 16,535 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $16.40, for a total value of $271,174.00. Following the completion of the transaction, the president now directly owns 2,374,051 shares of the company’s stock, valued at $38,934,436.40. This represents a 0.69 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.99, for a total value of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total value of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total value of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total value of $408,300.00.

Alignment Healthcare Trading Up 2.5 %

Shares of NASDAQ ALHC opened at $17.61 on Friday. The stock’s 50 day simple moving average is $14.90 and its 200 day simple moving average is $12.69. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The company has a market cap of $3.38 billion, a price-to-earnings ratio of -22.87 and a beta of 1.49. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $17.76.

Institutional Trading of Alignment Healthcare

Hedge funds have recently added to or reduced their stakes in the business. R Squared Ltd bought a new stake in Alignment Healthcare during the 4th quarter valued at $55,000. RiverPark Advisors LLC bought a new stake in Alignment Healthcare during the 4th quarter valued at $106,000. Tower Research Capital LLC TRC raised its stake in Alignment Healthcare by 146.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after acquiring an additional 6,286 shares in the last quarter. Ballentine Partners LLC bought a new stake in Alignment Healthcare during the 4th quarter valued at $121,000. Finally, Aigen Investment Management LP bought a new stake in Alignment Healthcare during the 4th quarter valued at $129,000. Institutional investors own 86.19% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Stifel Nicolaus lifted their target price on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Bank of America lifted their target price on Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. Stephens reiterated an “overweight” rating and issued a $17.00 target price on shares of Alignment Healthcare in a research report on Monday, February 24th. William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. Finally, JPMorgan Chase & Co. lifted their target price on Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a research report on Thursday, March 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $14.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.